| Literature DB >> 35622482 |
Ulrike D B Krammer1,2, Alexandra Sommer3, Sylvia Tschida1, Anna Mayer1, Stephanie V Lilja1, Olivier J Switzeny2, Berit Hippe1,2, Petra Rust1, Alexander G Haslberger1.
Abstract
Healthy mitochondria and their epigenetic control are essential to maintaining health, extending life expectancy, and improving cardiovascular performance. Strategies to maintain functional mitochondria during aging include training; cardiovascular exercise has been suggested as the best method, but strength training has also been identified as essential to health and healthy aging. We therefore investigated the effects of concurrent exercise training and dietary habits on epigenetic mechanisms involved in mitochondrial (mt) functions and biogenesis. We analyzed epigenetic biomarkers that directly target the key regulator of mitochondrial biogenesis, PGC-1α, and mtDNA content. Thirty-six healthy, sedentary participants completed a 12-week concurrent training program. Before and after the intervention, dried blood spot samples and data on eating habits, lifestyle, and body composition were collected. MiR-23a, miR-30e expression, and mtDNA content were analyzed using real-time quantitative polymerase chain reaction (qPCR) analysis. PGC-1α methylation was analyzed using bisulfite pyrosequencing. MiR-23a, miR-30e expression, and PGC-1α methylation decreased after the intervention (p < 0.05). PGC-1α methylation increased with the consumption of red and processed meat, and mtDNA content increased with the ingestion of cruciferous vegetables (p < 0.05). Our results indicate that concurrent training could improve mitochondrial biogenesis and functions by altering the epigenetic regulation. These alterations can also be detected outside of the skeletal muscle and could potentially affect athletic performance.Entities:
Keywords: PGC-1α; concurrent training; epigenetic; mitochondrial biogenesis; polyphenols
Year: 2022 PMID: 35622482 PMCID: PMC9143572 DOI: 10.3390/sports10050073
Source DB: PubMed Journal: Sports (Basel) ISSN: 2075-4663
Figure 1A graphic representation of the main signaling pathways in the regulation of skeletal muscle hypertrophy and mitochondrial biogenesis. Voluntary training alters primary signals such as mechanical stress or muscle energy status (AMP:ATP Ratio) and activates kinases/phosphatases in order to convey a specific exercise-induced signal. These pathways are regulated at several points, with significant crosstalk among the numerous signaling pathways creating a highly sensitive and complex transduction network. (The illustration was inspired by Methenitis [1] and Hawley et al. [11]). AMPK = AMP-activated Protein Kinase, PGC1-α = PPAR-γ Coactivator-1α, NRF1= Nuclear Respiratory Factor 1, NRF2 = Nuclear Factor Erythroid 2-related Factor 2, TFAM = mitochondrial Transcription Factor A, FAK = Focal Adhesion Kinase, TSC = Tuberous Sclerosis Complex, AKT = Protein Kinase B, mTOR = mammalian Target Of Rapamycin, IGF-1 = Insulin-like Growth Factor 1, PI3K = Phosphatidylinositide 3-Kinases, p38 MAPK = p38 Mitogen-activated Protein Kinase, JNK = Jun amino-terminal Kinase, ERK 1/2 = Extracellular signal-regulated Kinases 1/2, IRS-1 = Insulin Receptor Substrate 1, SIRT = Sirtuin, TORC1/2 = mTOR Complex 1/2, ROS = Reactive Oxygen Species, AMP:ATP = Adenosine Monophsphate: Adenosine Triphosphate ratio, NAD = Nicotinamide Adenine Dinucleotide, NADP = Nicotinamide Adenine Dinucleotide Phosphate.
Training Plan. During strength training, there should be 60–120 s breaks between the sets. Training B would start the following Monday, followed by endurance training on Tuesday.
| Monday | Tuesday | Wednesday | Thursday | Friday | Saturday | Sunday |
|---|---|---|---|---|---|---|
| Warm up | 30 to at least 60 min. in the last weeks of intervention | Warm up | - | Warm up | 30 to at least 60 min. in the last weeks of intervention | - |
| Working sets | Working sets | Working sets | ||||
| Cool down | Cool down | Cool down |
Rep = Repetition.
Details of pyrosequencing assays and primers used to measure CpG methylation.
| Assay ID | Primer | Sequence | No. of CpG Sites |
|---|---|---|---|
|
| fw: | 5′-TAT AGT TAT TTT GTT ATG AAA TAG GGA GTT TTG -3′ | 1 |
| rev: | 5′- biotin-CCA ATC ACA TAA CAA AAC TAT TAA AAA ATA A -3′ | ||
| seq: | 5′-GGA TTT TGG TTA TTA TAT GGT TAG G -3′ | ||
| Sequence to analyze: | GTT TYG TTT AGA GTT TG |
Fw = forward, rev = reverse, seq = sequence, biotin = biotinylating.
Participant characteristics.
| Total ( | Female ( | Male ( | |
|---|---|---|---|
| Age ± SD [years] | 31.86 ± 8.02 | 30.14 ± 8.51 | 34.27 ± 6.82 |
| BMI ± SD [T0, kg/m2] | 24.17 ± 2.95 | 23.78 ± 3.18 | 24.71 ± 2.61 |
| BMI ± SD [T1, kg/m2] | 23.88 ± 2.71 | 23.51 ± 2.95 | 24.40 ± 2.33 |
| BMI classes | |||
| Normal weight 18.5–24.9 kg/m2 | 58.3% | 61.9% | 53.3% |
| Overweight, 25–29.9 kg/m2 | 38.9% | 33.3% | 46.7% |
| Obesity grad I, 30–34.9 kg/m2 | 2.8% | 4.8% | - |
| Basal metabolic rate ± SD [T0, kcal] | 1481.11 ± 178.41 | 1355.71 ± 73.46 | 1656.67 ± 123.56 |
| Basal metabolic rate ± SD [T1, kcal] | 1495.81 ± 175.74 | 1369.05 ± 61.72 | 1673.27 ± 118.03 |
| LBM ± SD [T0, kg] | 51.93 ± 9.74 | 45.02 ± 4.96 | 61.60 ± 5.47 |
| LBM ± SD [T1, kg] | 52.44 ± 9.87 | 45.47 ± 4.72 | 62.20 ± 6.07 |
| BFM ± SD [T0, kg] | 20.06 ± 5.67 | 21.21 ± 6.08 | 18.44 ± 4.77 |
| BFM ± SD [T1, kg] | 18.53 ± 5.62 | 19.99 ± 5.84 | 16.47 ± 4.75 |
| BFP ± SD [T0, %] | 27.75 ± 6.21 | 31.24 ± 4.88 | 22.86 ± 4.31 |
| BFP ± SD [T1, %] | 26.04 ± 6.77 | 29.76 ± 5.27 | 20.83 ± 5.02 |
| Intake frequencies | |||
| Red/processed meat | |||
| Rarely or never | 44.4% | 57.2% | 26.6% |
| Once/week | 25.0% | 23.8% | 26.6% |
| 2–3×/week | 22.2% | 9.5% | 40.0% |
| >4×/week or daily | 8.4% | 9.5% | 6.8% |
| Cruciferous vegetables | |||
| Rarely or never | 58.3% | 57.1% | 60.0% |
| ≥once/week | 41.7% | 42.9% | 40.0% |
SD = Standard Deviation, BMI = Body Mass Index, LBM = Lean Body Mass, BFM = Body Fat Mass, BFP = Body Fat Percentage.
Figure 2Molecular changes following 12 weeks of concurrent training. (A) Change in PGC-1α methylation during the intervention (n = 27). (B) Change in miR-23a expression during the intervention (n = 36). (C) Change in miR-30e expression during the intervention (n = 36). The results are expressed as mean ± SD. * Shows significant p-values below 0.05 and *** p-values below 0.03 (paired t-test).
Main results of the analyzed marker.
| Marker | Total ( | Reduced Group ( | ||
|---|---|---|---|---|
| Fold Change ± SD | Fold Change ± SD | |||
| 1.49 ± 1.42 | 0.826 | 1.88 ± 1.45 | 0.024 * | |
| mtDNA | 1.09 ± 0.37 | 0.426 | 1.10 ± 0.39 | 0.583 |
| miR-23a-3p | 0.92 ± 0.35 | 0.023 * | 0.91 ± 0.36 | 0.028 * |
| miR-30e-3p | 0.94 ± 0.34 | 0.047 * | 0.94 ± 0.37 | 0.088 |
PGC-1α = Peroxisome Proliferator-activated Receptor Gamma Coactivator 1-Alpha, mtDNA = mitochondrial DNA, SD = Standard Deviation. * Shows significant p-values (paired t-test).
Figure 3Correlations, independent of the intervention. (A) Linear regression between body fat mass (BFM, kg) and PGC1A methylation. (B) Linear regression between PGC1A methylation and miR-23a expression. * Shows significant p-values.